A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway

By Nolan Ryan   Bree Andrea   Zutshi Anup  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 5, 2013-10 ,pp. : 609-622

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 7, 2015-01 ,pp. : 903-914

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 692-699

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Tuberculosis – Novel Drugs Based on Drug Targets Related to Toll-Like Receptors in Macrophages

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4404-4417

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics

By  

Current Pharmaceutical Design, Vol. 16, Iss. 9, 2010-03 ,pp. : 1063-1080

Bentham Science Publishers

Access to resources Recommend Favorite